Four weeks of treatment with n-acetyl cysteine (NAC) (1200mg/day) reduces lung oxidative stress and improves lung function in moderate-to-severe COPD subjects Source: Annual Congress 2009 - Drug effects in COPD Year: 2009
Effect of beta-alanine supplementation on muscle carnosine, oxidative and carbonyl stress, antioxidants and physical capacity in patients with COPD Source: Virtual Congress 2021 – A selection of the best abstracts in respiratory physiotherapy and exercise Year: 2021
COPD and oxidative stress: NAC‘s (n-acetylcysteine) effects Source: Annual Congress 2007 - Mechanisms and new treatments of COPD Year: 2007
Effects of antioxidant enzyme polymorphisms on ozone-induced lung function changes Source: Eur Respir J 2007; 30: 677-683 Year: 2007
Low dose of sodium hypochlorite impair lung function, inflammation and oxidative stress of naïve mice Source: International Congress 2019 – Novel insights from in vitro and in vivo models of lung disease Year: 2019
PP223 – N-Acetyl cysteine rescues neonatal lethality caused by HRas/NRas deficiency by improving lung maturation and decreasing oxidative stress Source: ERS Lung Science Conference 2021 Year: 2021
N-acetylcysteine increases manganese superoxide dismutase activity in septic rat diaphragms Source: Eur Respir J 2005; 26: 1032-1039 Year: 2005
Effects of edaravone, a free-radical scavenger, on bleomycin-induced lung injury in mice Source: Eur Respir J 2008; 32: 1337-1343 Year: 2008
2,2'-azobis (2-amidinopropane) dihydrochloride (AAPH) impairs lung mechanics, morphology and oxidative balance in rats Source: International Congress 2014 – Pathophysiological mechanisms at different scales Year: 2014
N-acetylcysteine attenuates the stress oxidative induced by chronic paraquat toxicity in different tissues Source: Eur Respir J 2006; 28: Suppl. 50, 650s Year: 2006
The effect of antioxidant tetrapeptide UPF1 on enzymes involved in glutathione metabolism in human bronchial epithelial cells exposed to oxidative stress Source: Annual Congress 2010 - Novel insights into the pathophysiology of asthma and COPD Year: 2010
Development of new treatments for complex chronic comorbidities Source: Research Seminar 2006 - Complexity of patients with multiple chronic diseases Year: 2006
Reduction of oxidative stress in successfully treated patients with community acquired pneumonia (CAP), as measured by redox status of coenzyme Q10 (%CoQ-10) Source: Annual Congress 2011 - New aspects in prevention and treatment of community-acquired pneumonia and lower respiratory tract infections Year: 2011
The effects of antioxidant therapy on lung clearance, pulmonary function test and oxidant stress in patients with COPD Source: Eur Respir J 2002; 20: Suppl. 38, 258s Year: 2002
The influence of N-acetylcysteine on oxidative stress in patients with COPD Source: Annual Congress 2010 - Novel insights into the pathophysiology of asthma and COPD Year: 2010
Stress response in ozon-induced lung injury is inhibited by ambroxol: evidence for antioxidative capacity Source: Eur Respir J 2001; 18: Suppl. 33, 412s Year: 2001
Inhibition of lung inflammation by a protein epitope mimetic (PEM) neutrophil elastase inhibitor, POL6014, in a sub-chronic tobacco smoke (TS) model in mice Source: Annual Congress 2013 –Novel drugs for the treatment of asthma and COPD Year: 2013
Homogenisation of induced sputum with N-acetyl-L-cysteine (NAC) is protective for sputum cells Source: Eur Respir J 2003; 22: Suppl. 45, 292s Year: 2003
Desferrioxamine attenuates minor lung injury following surgical acute liver failure Source: Eur Respir J 2009; 33: 1429-1436 Year: 2009
Effects of curcumin or dexamethasone on lung ischaemia-reperfusion injury in rats Source: Eur Respir J 2009; 33: 398-404 Year: 2009